Staff >> Faculty >> Dr. Auro Viswabandya

Dr. Auro Viswabandya MBBS, MD, DM

Professor, Haematology

Email: aurov@cmcvellore.ac.in

“Will be updated Soon”

“Will be updated Soon”

Professional Qualifications

• Clinical Fellowship in Malignant Haematology and Stem Cell Transplantation
  Princess Margaret Hospital, Toronto, ON,
  Canada – Oct 2009 till 30th June 2012.
• DM [Clinical Haematology] – (Doctor of Medicine),
  Christian Medical College, Vellore (2004)
  The MGR Medical University, Tamil Nadu, India.
• MD – [General Medicine] - (Doctor of Medicine),
  MKCG Medical College, Berhampur (1999),
  Berhampur University, Berhampur, Orissa, India
• MBBS (Bachelor of Medicine Bachelor of Surgery),
  SCB Medical College, Cuttack (1995),
  Utkal University, Bhubaneswar,
  Orissa, India.

Academic / Curricular Excellence

• Honours in Physiology
• Honours in Forensic Medicine and Toxicology
• Honours in Pathology
• Gold Medal in Social and Preventive Medicine
• Bishnupriya Devi Memorial award in Physiology

Life Membership Of Professional Bodies

• Indian Society of Haematology and Blood Transfusion
• Association of Physician of India
• Indian Medical Association

Professional Affiliation

• Member, Indian Society of Hematology and Blood Transfusion (ISHBT)
• Member, American Society of Haematology (ASH)
• Asia Pacific Bone Marrow Transplantation (APBMT)
• Member, Indian Medical Association (IMA)
• Member, Association of Physicians of India (API)
• Member, Asia Pacific Hematology Consortium (APHCON)

Reviewer for the following journals

• Indian Journal of Hematology and Transfusion (also in editorial board)
• Haemophilia
• Bone Marrow Transplantation

Medical Licenses

Degree	Registration Body	Registration Number
MBBS	Orissa Council of Medical Registration, Bhubaneswar, Orissa, India	12373
	Chennai Council of Medical Registration, Tamil Nadu, India	64588**
MD, General Medicine	Orissa Council of Medical Registration, Bhubaneswar, Orissa, India	12373
	Chennai Council of Medical Registration, Tamil Nadu, India	64588**
DM, Clinical Haematology	Chennai Council of Medical Registration, Tamil Nadu, India	64588
** I had to re-register myself in Tamil Nadu State as I am presently doing medical practice in this state.

Professional Appointments

• PROFESSOR – April 2010 till date - Department of Haematology, Christian Medical College, Vellore, Tamil Nadu.
• CLINICAL FELLOW - 1st October 2009 till 30th June 2012 - Department of Haematology, Princess Margaret Hospital, Toronto, Canada.
• ASSOCIATE PROFESSOR - April 2006 till April 2010 - Department of Haematology, Christian Medical College, Vellore, Tamil Nadu.
• ASSISTANT PROFESSOR - April 2004 till April 2006 - Department of Haematology, Christian Medical College, Vellore, Tamil Nadu.
• POSTGRADUATE SPECIALITY TRAINING IN HAEMATOLOGY April 2001- March 2004, Department of Haematology, Christian Medical College, Vellore, Tamil Nadu
• Visiting Professor to the Government of Odisha to help them to establish Bone Marrow Transplant Unit.

Phone: +91-416-228-2352 or 228-2890

Email: aurov@cmcvellore.ac.in

• Abraham A, George B, Ahmed R, Viswabandya A, Mathews V, Lakshmi KM, Srivastava VM, Chandy M, Srivastava A. Outcome of treatment with a low cost protocol in adults with t cell acute lymphoblastic leukaemia in a tertiary care centre in india. Leuk Lymphoma. 2013 Jun 17. [Epub ahead of print].
• Mathews V, George B, Viswabandya A, Abraham A, Ahmed R, Ganapule A, Sindhuvi E, Lakshmi KM, Srivastava A. Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts. PLoS One. 2013 Apr 26;8(4):e61637. doi: 10.1371/journal.pone.0061637.
• Rajamanickam M, Michael R, Sampath V, John JA, Viswabandya A, Srivastava A. Should ice be used in the treatment of acute haemarthrosis in haemophilia? Haemophilia. 2013 Apr 16. doi: 10.1111/hae.12163. [Epub ahead of print]
• Sumitha E, Jayandharan GR, Arora N, Abraham A, David S, Sankari Devi G, Shenbagapriya P, Nair SC, George B, Mathews V, Chandy M, Viswabandya A, Srivastava A. Molecular basis of quantitative fibrinogen disorders in 27 patients from India. Haemophilia. 2013 Apr 8. doi: 10.1111/hae.12143. [Epub ahead of print].
• Goel A, Nair SC, Viswabandya A, Masilamani VP, Rao SV, George A, Regi A, Jose R, Zachariah U, Subramani K, Eapen CE, Chandy G. Preliminary experience with use of recombinant activated factor VII to control postpartum hemorrhage in acute fatty liver of pregnancy and other pregnancy-related liver disorders. Indian J Gastroenterol. 2013 Mar 10. [Epub ahead of print].
• David S, Jayandharan GR, Abraham A, Jacob RR, Devi GS, Patkar N, Shaji RV, Nair SC, Viswabandya A, Ahmed R, George B, Mathews V, Chandy M, Srivastava A. Molecular basis of Wiskott-Aldrich syndrome in patients from India. Eur J Haematol. 2012 Oct;89(4):356-60.
• Jain PP, Parihar M, Ahmed R, Abraham A, Viswabandya A, George B, Mathews V, Srivastava A, Srivastava VM. Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia at diagnosis. Indian J Pathol Microbiol. 2012 Jul-Sep;55(3):347-51
• Chendamarai E, Balasubramanian P, George B, Viswabandya A, Abraham A, Ahmed R, Alex AA, Ganesan S, Lakshmi KM, Sitaram U, Nair SC, Chandy M, Janet NB, Srivastava VM, Srivastava A, Mathews V.Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy. Blood. 2012 Apr 12;119(15):3413-9. Epub 2012 Feb 28.
• Viswabandya A, Baidya S, Nair SC, Abraham A, George B, Mathews V, Chandy M, Srivastava A. Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from Southern India. Haemophilia. 2012 Jan 4. doi: 10.1111/j.1365-2516.2011.02730.x. [Epub ahead of print]
• Patkar N, Alex AA, B B, Ahmed R, Abraham A, George B, Viswabandya A, Srivastava A, Mathews V. Standardizing minimal residual disease by flow cytometry for precursor B lineage acute lymphoblastic leukemia in a developing country. Cytometry B Clin Cytom. 2012 Jul;82(4):252-8.
• Sellathamby S, Lakshmi KM, Busson M, Viswabandya A, George B, Mathews V, Chandy M, Charron D, Krishnamoorthy R, Tamouza R, Srivastava A. Polymorphisms in the immunoregulatory genes are associated with hematopoietic recovery and increased susceptibility to bacterial infections in patients with thalassaemia major undergoing matched related hematopoietic stem cell transplantation (HSCT). Biol Blood Marrow Transplant. 2012 Jan 14. [Epub ahead of print]
• Balasubramanian P, Desire S, Panetta JC, Lakshmi KM, Mathews V, George B, Viswabandya A, Chandy M, Krishnamoorthy R, Srivastava A. Population pharmacokinetics of cyclophosphamide in patients with thalassemia major undergoing HSCT.Bone Marrow Transplant. 2012 Jan 9. doi: 10.1038/bmt.2011.254. [Epub ahead of print]
• Chandran Nair S, Viswabandya A, Srivastava A. Diagnosis and management of von Willebrand disease: A developing country perspective. Semin Thromb Hemost. 2011 Jul; 37 (5): 587 – 94. Epub 2011 Nov 18.
• Mathews V, Chendamarai E, George B, Viswabandya A and Srivastava A. Treatment of acute promyelocytic leukemia with single agent arsenic trioxide. Mediterr J Hematol Infect Dis 2011; 3.
• Patkar N, Nair S, Alex AA, Parihar M, Manipadam MT, Arora N, Ahmed R, Abraham A, George B, Viswabandya A, Srivastava V, Srivastava A, Mathews V. Clinicopathological Features of Hepatosplenic T Cell Lymphoma: A Single Centre Experience from India.Leuk Lymphoma. 2011 Sep 15. [Epub ahead of print]
• Seema Thakur, Mala Ishrie, Renu Saxena, Sumita Danda, Rose Linda, Auro Viswabandya& I.C. Verma ATR-X syndrome in two siblings with a novel mutation (c.6718C>T mutation in exon 31). Indian J Med Res 134, October 2011, pp 483-486.
• Sumitha E, Jayandharan GR, David S, Jacob RR, Sankari Devi G, Bargavi B, Shenbagapriya S, Nair SC, Abraham A, George B, Viswabandya A, Mathews V, Chandy M, Srivastava A. Molecular basis of Bernard Soulier Syndrome in 27 patients from India.Thromb Haemost. 2011 Jun 23.  [Epub ahead of print]
• Parihar M, Ashok Kumar J, Sitaram U, Balasubramanian P, Abraham A, Viswabandya A, George B, Mathews V, Srivastava A. Cytogenetic analysis of acute myeloid leukaemia with t(8;21) from a tertiary care centre in India with correlation between clinicopathological characteristics and molecular analysis.Leuk Lymphoma. 2011 Jul 11. [Epub ahead of print]
• A. Mohapatra, A. Viswabandya, R. Samuel, A. N. Deepti, S. Madhivanan, G. T. John  NK /T cell lymphoma in a renal transplant recipient and review of literature. Indian Journal of Nephrology, 2011, Vol 21, No.1: 44-48.
• Chapla A, Jayandharan GR, Sumitha E, Sankari Devi G, Shenbagapriya P, Nair SC, Viswabandya A, George B, Mathews V, Srivastava A. Molecular basis of hereditary factor V deficiency in India: identification of four novel mutations and their genotype-phenotype correlation.Thromb Haemost. 2011 Jun 6;105(6):1120-3. Epub 2011 Apr 20.
• Manipadam MT, Nair S, Viswabandya A, Mathew L, Srivastava A, Chandy M. Non-Hodgkin lymphoma in childhood and adolescence: frequency and distribution of immunomorphological types from a tertiary care center in South India.World J Pediatr. 2011 Jun 1. [Epub ahead of print]
• Padankatti SM, Macaden AS, Cherian SM, Thirumugam M, Pazani D, Kalaiselvan M, John JA, Subbian E, Prakash H, Poonnoose PM, Kavitha ML, Devadarasini M, Viswabandya A, Mathews V, Srivastava A. A patient-prioritized ability assessment in haemophilia: the Canadian Occupational Performance Measure.Haemophilia. 2011 Feb 7. [Epub ahead of print]
• Gupta M, Ashok Kumar J, Sitaram U, Neeraj S, Nancy A, Balasubramanian P, Abraham A, Mathews V, Viswabandya A, George B, Chandy M, Srivastava A, Srivastava VM. The t(6;9)(p22;q34) in myeloid neoplasms: a retrospective study of 16 cases.Cancer Genet Cytogenet. 2010 Dec;203(2):297-302.
• Mathews V, George B, Chendamarai E, Lakshmi KM, Desire S, Balasubramanian P, Viswabandya A, Thirugnanam R, Abraham A, Shaji RV, Srivastava A, Chandy M. Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data.J Clin Oncol.2010 Aug 20;28(24):3866-71. Epub 2010 Jul 19.
• Viswabandya A, Baidya S, Nair SC, Lakshmi KM, Mathews V, George B, Chandy M, Srivastava A. Clinical manifestations of combined factor V and VIII deficiency: a series of 37 cases from a single center in India.Am J Hematol. 2010 Jul;85(7):538-9.
• George B, Mathews V,Viswabandya A, Lakshmi KM, Srivastava A, Chandy M. Allogeneic hematopoietic stem cell transplantation is superior to immunosuppressive therapy in Indian children with aplastic anemia-a single-center analysis of 100 patients.Pediatr Hematol Oncol. 2010 Mar;27(2):122-31. Acceptance: March 2010.
• Rajasekar R, Lakshmi KM, George B, Viswabandya A, Thirugnanam R, Abraham A, Chandy M, Srivastava A, Mathews V. Dendritic cell count in the graft predicts relapse in patients with hematological malignancies undergoing a HLA-matched related allogeneic peripheral blood stem cell transplant.Biol Blood Marrow Transplant. 2010 Feb 3. [Epub ahead of print].
• Markose P, Chendamarai E, Balasubramanian P, Velayudhan SR, Srivastava VM, Mathews V, George B, Viswabandya A, Srivastava A, Chandy M. Spectrum of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia from India with suspected resistance to imatinib-mutations are rare and have different distributions.Leuk Lymphoma. 2009 Dec;50(12):2092-5.
• Koshy G, Thomas N, Rajaratnam S, Simha A, Thomas M, Viswabandya A, Nagaraj C. Proptosis and polyuria. Hong Kong Med J. 2009 Dec;15(6):494-5.
• Mathews V, Nair SC, David S, Viswabandya A, Srivastava A. Management of Hemophilia in Patients with Inhibitors: The Perspective from Developing Countries. Semin Thromb Hemost. 2009 Nov;35(8):820-826. Epub 2010 Feb 18.
• Thirugnanam R, George B, Chendamarai E, Lakshmi KM, Balasubramanian P, Viswabandya A, Srivastava A, Chandy M, Mathews V. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.Biol Blood Marrow Transplant. 2009 Nov;15(11):1479-84.
• Desire S, Balasubramanian P, Bajel A, George B, Viswabandya A, Mathews V, Srivastava A, Chandy M. Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine.Med Oncol. 2009 Oct 15. [Epub ahead of print]
• Jayandharan GR, Nair SC, Poonnoose PM, Thomas R, John J, Keshav SK, Cherian RS, Devadarishini M, Lakshmi KM, Shaji RV, Viswabandya A, George B, Mathews V, Chandy M, Srivastava A. Polymorphism in factor VII gene modifies phenotype of severe haemophilia. Haemophilia. 2009 Aug 16. [Epub ahead of print].
• Rajasekar R, Mathews V, Lakshmi KM, George B, Viswabandya A, Chandy M, Srivastava A. Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant. Biol Blood Marrow Transplant. 2009 May;15(5):597-609.
• George B, Mathews V, Viswabandya A, Srivastava A, Chandy M. Fludarabine-based reduced intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia and fungal infections.Clin Transplant. 2009 Mar;23(2):228-32.
• Jebasingh KF, Koshy TG, Paul TV, Paul MJ, Abraham D, Viswabandya A. Pheochromocytoma and haemophilia: an unusual combination. Singapore Med J. 2009 Feb;50(2):e71-3.
• Varghese L, Viswabandya A, Mathew AJ. Dapsone, danazol, and intrapartum splenectomy in refractory ITP complicating pregnancy. Indian J Med Sci. 2008 Nov;62(11):452-5.
• Bajel A, George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol. Pediatr Blood Cancer. 2008 Nov;51(5):621-5.
• Goel A, Kumar J DI, Nair S, Joseph AJ, Viswabandya A, Eapen CE. Education and imaging. Hepatobiliary and pancreatic: spur cell anemia associated with alcoholic cirrhosis. J Gastroenterol Hepatol. 2008 Sep;23(9):1463.
• Mathews V, George B, Lakshmi KM, Viswabandya A, John JM, Sitaram U, Daniel D, Chandy M, Srivastava A. Impact of pretransplant splenectomy on patients with beta-thalassemia major undergoing a matched-related allogeneic stem cell transplantation. Pediatr Transplant. 2008 May 14. [Epub ahead of print]
• Viswabandya A, Mathews V, George B, Nair SC, Baidya S, Mammen JJ, Chandy M, Srivastava A. Successful surgical haemostasis in patients with von Willebrand disease with Koate((R))DVI. Haemophilia. 2008, July 14 (4); 763-7.
• Edison ES, Shaji RV, Devi SG, Moses A, Viswabandya A, Mathews V, George B, Srivastava A, Chandy M. Analysis of beta globin mutations in the Indian population: presence of rare and novel mutations and region-wise heterogeneity. Clin Genet. 2008 Apr;73(4):331-7.
• Rajasekar R, Mathews V, Lakshmi KM, Sellathamby S, George B, Viswabandya A, Daniel D, Chandy M, Srivastava A. Plasmacytoid Dendritic Cell Count on Day 28 in HLA-Matched Related Allogeneic Peripheral Blood Stem Cell Transplant Predicts the Incidence of Acute and Chronic GVHD.Biol Blood Marrow Transplant. 2008 Mar; 14(3):344-350.
• George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M. Fludarabine based reduced intensity conditioning regimens in children undergoing allogeneic stem cell transplantation for severe aplastic anemia.Pediatr Transplant. 2008 Feb; 12(1):14-9.
• Bajel A, George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M. Adult ALL: treatment outcome and prognostic factors in an Indian population using a modified German ALL (GMALL) protocol.Leukemia. 2007 Oct;21(10):2230-3.
• Poonnoose PM, Thomas R, Keshava SN, Cherian RS, Padankatti S, Pazani D, Kavitha ML, Devadarasini M, Bhattacharji S, Viswabandya A, John JA, Macaden AS, Mathews V, Srivastava A. Psychometric analysis of the Functional Independence Score in Haemophilia (FISH).Haemophilia. 2007 Sep; 13(5):620-6.
• Mathews V, George B, Deotare U, Lakshmi KM, Viswabandya A, Daniel D, Chandy M, Srivastava A. A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with beta thalassemia major undergoing a matched related allogeneic stem cell transplantation.Biol Blood Marrow Transplant. 2007 Aug; 13(8):889-94.
• Manipadam MT, Viswabandya A, Srivastava A. Primary splenic marginal zone lymphoma with florid granulomatous reaction-A case report and review of literature. Pathol Res Pract. 2007;203(4):239-43.
• Jayandharan G, Spreafico M, Viswabandya A, Chandy M, Srivastava A, Peyvandi F. Mutations in the MCFD2 gene are predominant among patients with hereditary combined FV and FVIII deficiency (F5F8D) in India.Haemophilia. 2007 Jul; 13(4):413-9.
• Lee VN, Srivastava A, Nithyananth M, Kumar P, Cherian VM, Viswabandya A, Mathews V, George B, Venkatesh K, Nair SC, Chandy M, Sundararaj GD. Fracture neck of femur in haemophilia A - experience from a cohort of 11 patients from a tertiary centre in India.Haemophilia. 2007 Jul; 13(4):391-4.
• Jayandharan GR, Viswabandya A, Nair SC, Chandy M, Srivastava A. Molecular basis of hereditary factor VII deficiency in India: five novel mutations including a double missense mutation (Ala191Glu; Trp364Cys) in 11 unrelated patients.Haematologica. 2007 Jul; 92(7):1002-3.
• George B, Mathews V, Viswabandya A, Kavitha ML, Srivastava A, Chandy M. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia.Bone Marrow Transplant. 2007 Jul;40(1):13-18.
• Subramaniam K, George B, Mathews V, Viswabandya A, Srivastava A, Chandy M. Salvage with a mini allograft after primary engraftment failure following autologous transplant for multiple myeloma. Bone Marrow Transplant. 2007 , Feb 39 (4), 239-240.
• Deotare UR, Viswabandya A, Mathews V, George B, Srivastava A, Chandy M. Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation. Bone Marrow Transplant. 2006 Jun;37(12):1149-50.
• Sellathamby S, Balasubramanian P, Sivalingam S, Shaji RV, Mathews V, George B, Viswabandya A, Srivastava A, Chandy M.  Developing an algorithm of informative markers for evaluation of chimerism after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2006 Apr; 37(8):751-5.
• Jayandharan GR, Viswabandya A, Baidya S, Nair SC, George B, Mathews V, Chandy M, Srivastava A. Mutations in coagulation factor XIII A gene in eight unrelated Indians. Five novel mutations identified by a novel PCR-CSGE approach. Thromb Haemost. 2006 Mar;95(3):551-6.
• Mathews V, Desire S, George B, Lakshmi KM, Rao JG, Viswabandya A, Bajel A, Srivastava VM, Srivastava A, Chandy M. Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of genetic polymorphisms on the incidence of hepatotoxicity. Leukemia. 2006 Mar 20(5); 881-3.
• George B, Mathews V, Viswabandya A, Srivastava A, Chandy M.Infections in children undergoing allogeneic bone marrow transplantation in India. Pediatr Transplant. 2006 Feb;10(1):48-54.
• Mathews V, George B, Lakshmi KM, Viswabandya A, Bajel A, Balasubramanian P, Shaji RV, Srivastava VM, Srivastava A, Chandy M. Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity.Blood. 2006 Apr 1; 107(7):2627-32.
• Mathews V, Viswabandya A, Baidya S, George B, Nair S, Chandy M, Srivastava A.Surgery for hemophilia in developing countries. Semin Thromb Hemost. 2005 Nov;31(5):538-43.
• S.Damodar, A. Viswabandya, B.George, V. Mathews, M. Chandy and A. Srivastava. Dapsone for Chronic Idiopathic Thrombocytopenic Purpura in Children and Adults – A Report of 90 patients. Eur J Haematol. 2005 Oct; 75(4):328-31.
• Jayandharan G, Viswabandya A, Baidya S, Nair SC, Shaji RV, George B, Chandy M, Srivastava A. Six novel mutations including triple heterozygosity for Phe31Ser, 514delT and 516T fi G factor X gene mutations is responsible for congenital factor X deficiency in patients of Nepali and Indian origin. J Thromb Haemost. 2005 Jul;3(7):1482-7.
• Jayandharan G, Viswabandya A, Baidya S, Nair SC, Shaji RV, Chandy M, Srivastava A. Molecular genetics of hereditary prothrombin deficiency in Indian patients: identification of a novel Ala362!Thr (Prothrombin Vellore 1) mutation. J Thromb Haemost. 2005 Jul; 3(7):1446-53.
• George B, Mathews V, Viswabandya A, Kavitha N, Srivastava A, Chandy M. Acute and chronic graft-versus-host disease (GVHD) in patients undergoing allogeneic BMT for thalassaemia major. Biology of Blood and Marrow Transplantation 2005 Feb: Volume 11, Issue 2, Supplement 1; 9-10.
• K. Fischer, H. M. Van Den Berg, R. Thomas, S. Kumar, P. Poonnoose, A. Viswabandya, V. Mathews, M. L. Kavitha, S. Bhattacharji, A. Srivastava. Dose and outcome of care in haemophilia how do we define cost-effectiveness? Haemophilia 2004, Vol 10, S4; 216 – 220.
• Samal KK, Parija BL, Nanda MK, Viswabandya A, Patnaik SR. Alprazolam poisoning. Journal of Association of Physician of India. 1999, Nov 47 (11); 1117.

http://www.ncbi.nlm.nih.gov/pubmed?term=Auro%20Viswabandya%20%20vellore